Zoommed Inc. reported audited consolidated financial results for the fourth quarter and full year ended May 31, 2012. For the three-month period ended May 31, 2012, the company reported operating revenue of CAD 770,324, revenue which were relatively stable throughout the other quarters. The rather exceptional revenue of CAD 1,255,078 during the fourth quarter is attributable to the sale of rights to use the PraxisLab software totaling CAD 730,000. The company reported a net loss of CAD 435,961 for the three-month period ended May 31, 2012, or CAD 0.003 per basic and diluted share compared to a net loss of CAD 418,712 or CAD 0.003 per basic and diluted share for the corresponding period of 2011.

For the year, the company reported total revenue of CAD 2,618,451 against CAD 2,885,588 for the last year. LBITDA was CAD 2,198,212 against CAD 2,875,542 for the last year. Loss before income taxes and net loss and comprehensive loss for the period was CAD 3,085,727 or CAD 0.024 per basic and diluted share against CAD 3,705,117 or CAD 0.032 per basic and diluted share for the last year. Cash flows used in operating activities was CAD 1,077,981 against CAD 1,894,716 for the last year. Acquisition of fixed assets was CAD 55,165 against CAD 307,802 for the last year. Acquisition of intangible assets was CAD 472,286 against CAD 242,266 for the last year.